The expression of the chemotherapy-induced upregulated EMT markers (VIM and Snail) and stem cell markers (CD44 and CD133) in ovarian cancer was also reserved by GLI1 knockdown (Fig. 6a, b). This evidence concerns the gene PROM1 and ovarian carcinoma.